stockrowAlcon
ALC Healthcare Medical Instruments & Supplies
Alcon’s revenue for fiscal 2025 (year ended December 2025) was $10.4 billion, up 4.94% from fiscal 2024.
- Revenue
- +8.74%
- EPS
- −100.0%
- Free cash flow
- −0.54%
- Total debt
- −0.55%
Quarter to June 2026, against a year earlier
Follow ALC
Alert me
Alcon (ALC) EV/Sales
As of 5 November 2026, Alcon (ALC) trades at a EV/Sales of 3.7×. Over the past ten years it has ranged from 0.0× (June 2019) to 5.8× (September 2021); the current reading is higher than 13% of that period. That is above the Medical Instruments & Supplies industry median of 2.8× and above the Healthcare sector median of 3.5×.
EV/Sales, daily
Embed this chart
Annual newest first
| Period | EV/Sales | Change |
|---|---|---|
| FY2025 | 4.0× | (10.64%) |
| FY2024 | 4.5× | 2.64% |
| FY2023 | 4.4× | 2.16% |
| FY2022 | 4.3× | (20.94%) |
| FY2021 | 5.5× | 6.95% |
| FY2020 | 5.1× | 26.39% |
| FY2019 | 4.0× | — |
| FY2018 | 0.0× | — |
| FY2017 | 0.0× | — |
| FY2016 | 0.0× | — |
Quarterly newest first
| Period | EV/Sales | Change |
|---|---|---|
| Jun 2026 | 3.3× | (11.60%) |
| Mar 2026 | 3.7× | (7.35%) |
| Dec 2025 | 4.0× | 2.86% |
| Sep 2025 | 3.9× | (16.36%) |
| 28 more quarters | Free account |
Against its own ten years
EV/Sales against peers
| Company | EV/Sales |
|---|---|
| MDLN Medline Inc. compare | 1.5× |
| BAX Baxter International Inc. compare | 1.7× |
| SOLV Solventum Corporation compare | 2.4× |
| ALGN Align Technology, Inc. compare | 2.4× |
| BDX Becton, Dickinson and Company compare | 3.4× |
| COO The Cooper Companies, Inc. compare | 3.5× |
| ALC Alcon | 3.7× |
| RMD ResMed Inc. compare | 5.8× |
| WST West Pharmaceutical Services, Inc. compare | 8.1× |
| Medical Instruments & Supplies industry median | 2.8× |
| Healthcare sector median | 3.5× |
| Market median | 2.1× |
What EV/Sales is
EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.
((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)
More on ALC
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Operating margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Current ratio
- Total debt
- Shares outstanding
- Book value per share
- Revenue growth
- Piotroski F-score
- Beneish M-score
- The full statement